ES2013408A6 - Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento. - Google Patents

Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento.

Info

Publication number
ES2013408A6
ES2013408A6 ES8901049A ES8901049A ES2013408A6 ES 2013408 A6 ES2013408 A6 ES 2013408A6 ES 8901049 A ES8901049 A ES 8901049A ES 8901049 A ES8901049 A ES 8901049A ES 2013408 A6 ES2013408 A6 ES 2013408A6
Authority
ES
Spain
Prior art keywords
epidermal growth
polypeptides
binding polypeptides
compounds
factor receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8901049A
Other languages
English (en)
Inventor
Joseph P Brown
Daniel R Twardzik
Hans Marquardt
Goerge J Todaro
A Gregory Bruce
Timothy M Rose
Anthony F Purchio
Shiu-Lok Hu
Wen Chang
Suo Win Liu
Thomas J Franceschini
Mohammed Shoyab
Greg Plowman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of ES2013408A6 publication Critical patent/ES2013408A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)

Abstract

METODO PARA PREPARAR POR BIOTECNOLOGIA POLIPEPTIDOS QUE TIENEN ACTIVIDAD DE FACTOR DE CRECIMIENTO. CONSISTE EN COMBINAR EN SERIE DESOXINUCLEOTIDOS PARA PRODUCIR UNA SECUENCIA DE ADN CODIFICADORA DE UN POLOPEPTIDO DE AL MENOS TRES DOMINIOS FIJABLE A RECEPTORES DE EGF, Y LIGAR A LA PORCION SINTETIZADA CUALQUIER SECUENCIA DE ADN REMANENTE. ASIMISMO, SE LIGA UNA REGION REGULADORA DE INICIACION DE TRANSCRIPCION/TRADUCCION AGUAS ARRIBA DE DICHA SECUENCIA DE ADN, SE LIGA AGUAS ABAJO DEL TERCER DOMINIO DEL POLIPEPTIDO UNA SECUENCIA REGULADORA DE TERMINACION DE TRANSCRIPCION/TRADUCCION, SE TRANSFORMA CON EL CASETE DE EXPRESION ASI OBTENIDO UNA CELULA HOSPEDANTE PROVINIENTE DE BACTERIAS, LEVADURAS, INSECTOS O MAMIFEROS, SE HACE CRECER DICHA CELULA EN UN MEDIO DE CULTIVO APROPIADO Y SE AISLA EL POLIPEPTIDO PRODUCIDO. ESTE ES UTIL COMO MITOGENO, ADITIVO NUTRICIO, MEDIO DE ENSAYO DE RECEPTORES DE EGF Y AGENTE DE CURACION Y CICATRIZACION DE HERIDAS.
ES8901049A 1988-03-24 1989-03-22 Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento. Expired - Lifetime ES2013408A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17265388A 1988-03-24 1988-03-24

Publications (1)

Publication Number Publication Date
ES2013408A6 true ES2013408A6 (es) 1990-05-01

Family

ID=22628611

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8901049A Expired - Lifetime ES2013408A6 (es) 1988-03-24 1989-03-22 Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento.

Country Status (22)

Country Link
JP (1) JPH0279981A (es)
KR (1) KR890014743A (es)
AU (2) AU3169589A (es)
BE (1) BE1004202A5 (es)
CH (1) CH681081A5 (es)
DE (1) DE3910084A1 (es)
DK (1) DK146789A (es)
ES (1) ES2013408A6 (es)
FI (1) FI891308A (es)
FR (1) FR2632321A1 (es)
GB (1) GB2219799B (es)
GR (1) GR1000876B (es)
HU (1) HUT50501A (es)
IE (1) IE890950L (es)
IL (1) IL89673A0 (es)
IT (1) IT1234961B (es)
LU (1) LU87489A1 (es)
NL (1) NL8900724A (es)
NO (1) NO891273D0 (es)
NZ (1) NZ228427A (es)
PT (1) PT90118B (es)
SE (1) SE8901031L (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
EP0444961A1 (en) * 1990-03-02 1991-09-04 Bristol-Myers Squibb Company Her3: A novel EGF receptor homolog
EP0739984A1 (en) * 1995-04-26 1996-10-30 San Tumorforschungs-Gmbh Bivalent polypeptides containing at least two domains
US6852506B1 (en) 1996-04-10 2005-02-08 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein
WO1997038002A1 (en) * 1996-04-10 1997-10-16 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0108132A1 (en) * 1982-05-06 1984-05-16 Applied Molecular Genetics Inc. The manufacture and expression of genes for urogastrone and polypeptide analogs thereof
JPS6028994A (ja) * 1983-07-08 1985-02-14 Wakunaga Seiyaku Kk 〔２１―ロイシン〕ヒトウロガストロン
WO1985002198A1 (en) * 1983-11-01 1985-05-23 Amgen Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides
JP2554459B2 (ja) * 1984-07-02 1996-11-13 アース製薬 株式会社 β−ウロガストロン遺伝子、対応プラスミド組換体及び対応形質転換体
JPS62501071A (ja) * 1984-10-30 1987-04-30 オンコゲン 成長因子活性を有する新規なポリペプチド及び該ポリペプチドをコ−ドする核酸配列
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
GB2210618B (en) * 1987-10-08 1991-10-16 British Bio Technology Synthetic egf gene
EP0314184B1 (en) * 1987-10-30 1995-12-13 Bristol-Myers Squibb Company Expression plasmids
JP2970811B2 (ja) * 1987-10-30 1999-11-02 オンコゲン ア リミテッド パートナーシップ 原核生物細胞中にポリペプチドを調製するための発現システム

Also Published As

Publication number Publication date
JPH0279981A (ja) 1990-03-20
IL89673A0 (en) 1989-09-28
FI891308A (fi) 1989-09-25
DK146789D0 (da) 1989-03-22
LU87489A1 (fr) 1989-10-26
AU2990492A (en) 1993-03-04
FR2632321A1 (fr) 1989-12-08
DE3910084A1 (de) 1989-11-16
SE8901031L (sv) 1989-09-25
GB8906758D0 (en) 1989-05-10
SE8901031D0 (sv) 1989-03-22
IE890950L (en) 1989-09-24
GR1000876B (el) 1993-03-16
NL8900724A (nl) 1989-10-16
CH681081A5 (es) 1993-01-15
IT8919917A0 (it) 1989-03-24
KR890014743A (ko) 1989-10-25
PT90118B (pt) 1994-07-29
IT1234961B (it) 1992-06-09
GR890100185A (en) 1990-01-19
NZ228427A (en) 1993-03-26
FI891308A0 (fi) 1989-03-20
HUT50501A (en) 1990-02-28
GB2219799A (en) 1989-12-20
PT90118A (pt) 1989-11-10
GB2219799B (en) 1992-10-14
DK146789A (da) 1989-09-25
AU3169589A (en) 1989-09-28
BE1004202A5 (fr) 1992-10-13
NO891273D0 (no) 1989-03-22

Similar Documents

Publication Publication Date Title
ES527418A0 (es) Un procedimiento para preparar un catalizador de fischer-tropsch que contiene cobalto,zirconio o titanio y silice
ES8502878A1 (es) Un procedimiento para la preparacion de un catalizador adecuado para convertir una mezcla de monoxido de carbono e hidrogeno en hidrocarburos
DE69813021D1 (de) Kleinporige kristalline titan-molekularsieb-zeolithen und ihre verwendung in gastrennungsverfahren
HK1007335A1 (en) Production of insulin-like growth factor binding protein
MY106507A (en) Antibody antagonists of human interleukin-4
DE50015156D1 (de) Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
ATE314337T1 (de) Verfahren zur hydration von olefinen
ES2013408A6 (es) Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento.
DE69419396T2 (de) Polyurethanzusammensetzung zur Verwendung als dispergierende Bindemittel
DE69102651D1 (de) Proteaseresistenter pdgf und dessen verwendungen.
DE3873810D1 (de) Zk-5 zeolith.
BR9713159A (pt) Composição substancialmente sólida, composto, composição de sal substancialmente sólida, mistura, e, processo para preparar um composto
DK440988D0 (da) Monoklonalt antistof, som er specifikt over for neutrophilocyter
IL97927A0 (en) Soluble,truncated gamma-interferon receptors
DE69211059T2 (de) Borsilazane als Binder zur Herstellung gesinterter Siliciumcarbidmonolithe
ES8802074A1 (es) Un metodo para preparar un vector de expresion que tiene un sistema de replicacion funcional en un microorganismo hospedante
CA1269113C (en) GUNITABLE REFRACTORY COMPOSITION
EP0154924A3 (en) Unsaturated polyesters with low viscosity, and their use as binder for monomerless patching compounds
BR8404293A (pt) Processo para sintetizar um material de peneira molecular silicosa cristalina sintetica,material de peneira molecular,composicao catalisadora e uso do material
CN207875206U (zh) 一种卷宗整理器
DK0804450T3 (da) Fremgangsmåde til fremstilling af palatinitol
DE602004013509D1 (de) Verwendung einer wasser- oder lufthärtenden Bindemittelzusammensetzung zur Herstellung von Produkten mit der Erscheinungsform und den Eigenschaften von Naturstein
MY120191A (en) Mammalian cytokine-like polypeptide-10
SU1412265A1 (ru) ФТОРАЛКИЛСОДЕРЖАЩИЕ β-КЕТОЭФИРАТЫ ТРЕХВАЛЕНТНОГО ЛАНТАНА ИЛИ ТРЕХВАЛЕНТНОГО КОБАЛЬТА КАК КАТАЛИЗАТОРЫ В СИНТЕЗЕ ПОЛИУРЕТАНОВ
RU95109475A (ru) Сырьевая смесь